When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Foodborne E coli infection

Última revisão: 11 Dec 2025
Última atualização: 08 Feb 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • diarrhoea
  • history of travel, contact with contaminated food, or contact with infected person
Detalhes completos

Outros fatores diagnósticos

  • abdominal pain or discomfort
  • volume depletion
  • fever
  • nausea/vomiting
  • anorexia
  • lethargy
Detalhes completos

Fatores de risco

  • ingestion of contaminated food products or water
  • travel
  • poor hygiene practices
  • infantile or advanced age (<5 years and >60 years)
  • contact history
  • immunocompromised state
  • contact with infected animals
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • stool cultures
  • FBC
  • renal function and electrolytes
Detalhes completos

Investigações a serem consideradas

  • identification of Shiga toxin-producing E coli infection
  • blood cultures
  • inflammatory markers (CRP and/or erythrocyte sedimentation rate)
  • abdominal x-ray
  • endoscopy
  • abdominal CT scan
Detalhes completos

Algoritmo de tratamento

Inicial

all patients

AGUDA

confirmed enterotoxigenic positive

confirmed enterohaemorrhagic positive

other Escherichia coli serotypes

Colaboradores

Autores

Eli D. Ehrenpreis, MD, FACG, AGAF

Associate Director for Research

Internal Medicine Residency

Advocate Lutheran General Hospital

Park Ridge

IL

Declarações

EDE is a CEO for E2Bio Life Sciences LLC and G.I. Pharmaceuticals Inc. E2Bio Life Sciences LLC has developed Bocaliner, an FDA-registered class 1 medical device designed to enhance the efficacy of topical medicines applied to the oral cavity. G.I. Pharmaceuticals Inc. has medical treatments for oral leukoplakia designed to prevent oral cancer, and a new medicine for anal pruritis.

Agradecimentos

Dr Eli D. Ehrenpreis would like to gratefully acknowledge the assistance of Dr Thomas Adam Wichelmann, who contributed to this update. Dr Ehrenpreis would also like to acknowledge Dr Alexandra Kent and Professor Satis Keshav, the previous contributors to this topic.

Declarações

TAW, AK, and SK declare that they have no competing interests.

Revisores

Andrew Poullis, BSc, MBBS, MD, FRCP

Consultant Gastroenterologist

St George’s Hospital

London

UK

Declarações

AP declares that he has no competing interests.

Fiona Cooke, MA, PhD, MSc, FRCPath, MRCP, DTM&H

Research Fellow and Medical Microbiologist

Wellcome Trust Sanger Institute

Department of Microbiology

Addenbrooke's Hospital

Cambridge

UK

Declarações

FC declares that she has no competing interests.

Houssam E. Mardini, MD, MPH, FACP

Voluntary Assistant Professor of Medicine

Digestive Health & Nutrition Center of Ashland

Ashland

KY

Declarações

HEM declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998 Jan;11(1):142-201.Texto completo  Resumo

Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004 Feb;2(2):123-40.Texto completo  Resumo

American Medical Association; American Nurses Association-American Nurses Foundation; Centers for Disease Control and Prevention; Center for Food Safety and Applied Nutrition, Food and Drug Administration; Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004 Apr 16;53(RR-4):1-33.Texto completo  Resumo

Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-e80.Texto completo  Resumo

Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 2: preparing international travelers - travelers' diarrhea. May 2023 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Differentials

    • Viral gastroenteritis
    • Alternative foodborne bacterial gastroenteritis/traveller's diarrhoea
    • Amoebiasis
    Mais Differentials
  • Guidelines

    • Infectious diarrhea - guideline for investigation
    • E. coli (Escherichia coli) infection
    Mais Guidelines
  • Patient information

    Diarrhoea in adults

    Diarrhoea in children

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer